TTRX·90021W105·US·equity·Healthcare - Biotechnology-13D/G
TTRX (TURN THERAPEUTICS INC) is held by 10 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($223,222), BROWN BROTHERS HARRIMAN & CO ($75,802), XTX Topco Ltd ($63,126). Net institutional sentiment: Bearish.
See how TTRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer